SCHEMBL4797482

SCHEMBL4797482

COc1cc2[nH]nc(C(=O)N3CCN(CC(=O)c4ccc(F)cc4)CC3)c2cc1OC

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 13/20 0.62
HTR2C P28335 8/20 0.60
ALDH1A1 P00352 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
MAPT P10636 1/20 0.53
CYP2C19 P33261 1/20 0.53
KCNH2 Q12809 2/20 0.52
TLR8 Q9NR97 3/20 0.52
TLR7 Q9NYK1 2/20 0.52
ABL1 P00519 1/20 0.48
BCR P11274 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4783291 0.87 HTR2A (0.61) HTR2AHTR2CALDH1A1KCNH2ABL1
SCHEMBL14205208 0.87 HTR2A (0.61) HTR2AHTR2CKCNH2
SCHEMBL4782575 0.87 HTR2A (0.65) HTR2AHTR2CALDH1A1KCNH2ABL1
SCHEMBL4781852 0.86 HTR2A (0.66) HTR2AHTR2CALDH1A1KCNH2ABL1
SCHEMBL4784431 0.86 HTR2A (0.66) HTR2AHTR2CALDH1A1KCNH2ABL1
SCHEMBL4784682 0.85 HTR2A (0.62) HTR2AHTR2CALDH1A1KCNH2ABL1
SCHEMBL4784566 0.84 HTR2A (0.62) HTR2AHTR2CALDH1A1CYP1A2CYP3A4
SCHEMBL4794769 0.84 HTR2A (0.67) HTR2AHTR2CKCNH2ABL1BCR
SCHEMBL4783248 0.84 HTR2A (0.67) HTR2AHTR2CMAPTKCNH2ABL1
SCHEMBL4732167 0.82 HTR2A (0.65) HTR2AHTR2CALDH1A1KCNH2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008054748-A2 INDAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-05-08 WO disclosed
WO-2008054748-A2 INDAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-05-08 WO disclosed